MFS
VERV

Mirabella Financial Services’s Verve Therapeutics VERV Stock Holding History

Mirabella Financial Services’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,320
Closed -$673K – 613
2021
Q3 		$673K Buy
+14,320
New +$842K 0.09% 206

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirabella Financial Services's VERV Position: Q4 2021 in Review

Mirabella Financial Services sold out of Verve Therapeutics (VERV) in Q4 2021, closing a stake of 14,320 shares — an estimated $673K sold.

Mirabella Financial Services first reported a position in VERV in Q3 2021 and held it in 1 quarter. The position peaked at $673K in Q3 2021. 96 funds tracked by Wall St. Rank hold VERV as of Q4 2021.

  • Mirabella Financial Services reported no remaining Verve Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Mirabella Financial Services sold 14,320 Verve Therapeutics shares in Q4 2021, an estimated $673K.
  • Mirabella Financial Services first reported a position in Verve Therapeutics in Q3 2021 and held it in 1 quarter.
  • Mirabella Financial Services's Verve Therapeutics position peaked at $673K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Verve Therapeutics as of Q4 2021.

Based on Mirabella Financial Services's 13F filing for Q4 2021, filed 14 Feb 2022.